Medical Weight Loss for Oak Park, Illinois Residents
Oak Park, Illinois residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Oak Park through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Oak Park Residents Choose New Hope Weight Loss
Oak Park patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Illinois and beyond since 2020.
Oak Park is served through telehealth from our Costa Mesa, California clinic. The full physician-supervised GLP-1 program runs by secure video, with compounded medication shipped to your Oak Park address.
For Oak Park, medical weight loss is delivered online from our Costa Mesa, California practice, with no travel required. We care for patients throughout downtown Oak Park and the near western edge of Chicago in Cook County. Compounded semaglutide and tirzepatide ship directly to your door in Illinois, and a licensed physician reviews every plan before anything is prescribed.
Whether you live in central Oak Park or its outskirts, you get exactly the same care and the same price. We accept HSA, FSA, Klarna, and Affirm, with no mandatory membership and no surprise charges for Oak Park patients.
GLP-1 Weight Loss Programs Available
Compounded semaglutide, from $166/mo (90-day program $499)
The 90-day Metabolic Reset is our most-chosen plan. Semaglutide shares its active ingredient with Wegovy® and Ozempic®; in trials of the branded drug, patients lost an average of 15-17% of body weight under physician supervision.
Compounded tirzepatide, from $233/mo
Tirzepatide's dual GLP-1/GIP action reached up to 22.5% body-weight loss in trials of the branded medication, the advanced option for Oak Park patients.
The physician review is a flat $119, with medication billed separately; HSA, FSA, Klarna, and Affirm are accepted.
How Telehealth Works for Oak Park
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Oak Park address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Oak Park
How do I get treatment from Oak Park?
As a Oak Park, Illinois patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Oak Park?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Oak Park in cold-pack packaging, no lines and no drive.
How much does it cost for Oak Park patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Oak Park do you serve?
We serve patients from across Oak Park by telehealth, including downtown Oak Park and the near western edge of Chicago in Cook County.
Are there hidden fees for Oak Park patients?
No. Oak Park patients pay the same flat, stated pricing: a $119 physician visit, then compounded semaglutide from $166/month or tirzepatide from $233/month with medication billed separately. There is no membership lock-in and no distance surcharge.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Oak Park, Illinois by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.